Publication | Closed Access

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure

HemodialysisUrologyRenal DiseaseRenal FunctionCardiovascular DiseaseMedicineKidney FailureHematocrit LevelDialysis TherapyPredialysis PatientsCardiovascular EffectChronic Kidney DiseaseNephrology